MICHAEL VOLK to Antiviral Agents
This is a "connection" page, showing publications MICHAEL VOLK has written about Antiviral Agents.
Connection Strength
1.018
-
Trends in hepatitis C treatment uptake in the United States. Hepatology. 2014 Aug; 60(2):768-9.
Score: 0.292
-
Antiviral therapy for hepatitis C: why are so few patients being treated? J Antimicrob Chemother. 2010 Jul; 65(7):1327-9.
Score: 0.219
-
Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009 Dec; 50(6):1750-5.
Score: 0.213
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
Score: 0.104
-
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1.
Score: 0.100
-
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008.
Score: 0.089